The state of Nevada currently has 3 active clinical trials seeking participants for Healthy research studies. These trials are conducted in various cities, including Las Vegas, Henderson, Reno and Pahrump.
Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib
Recruiting
A study to evaluate the impact of Obicetrapib on the PK levels of Drospirenone and Ethinyl Estradiol (COC) in 30 adult female, healthy volunteers.
Gender:
Female
Ages:
Between 18 years and 35 years
Trial Updated:
02/13/2024
Locations: NOVUM, Las Vegas, Nevada
Conditions: Healthy Volunteers
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Recruiting
The main purpose of this study is to look if the study drug, tirzepatide, gets into the breast milk and if yes, how long it takes the body to get rid of it. The study drug will be given as a single injection under the skin in healthy lactating females. For each participant, the total duration of the study will be approximately 8 weeks, including screening.
Gender:
Female
Ages:
18 years and above
Trial Updated:
10/10/2023
Locations: Las Vegas Clinical Research Unit - PPD, Las Vegas, Nevada
Conditions: Healthy
Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women
Recruiting
This study is designed to characterize the excretion of bempedoic acid or bempedoic acid and ezetimibe into mature breast milk of healthy lactating women and assess the exposure to the breast fed infant by estimating the daily infant dosage and the relative infant dose (RID) of bempedoic acid or bempedoic acid and ezetimibe in breast milk after 6 consecutive daily doses of bempedoic acid or bempedoic acid/ezetimibe FCDP.
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
08/27/2023
Locations: PPD Development, Las Vegas Research Unit, Las Vegas, Nevada
Conditions: Healthy Lactating Women